[5] Impairment of either fatty acid metabolism or glycogen metabolism leads to decreased ATP (energy) production
However, in states of leptin resistance such as obesity, this regulatory mechanism may be impaired (102, 103)
Most Medicare plans do not cover weight loss medications, unless the drug is approved for another condition, like diabetes
Food and beverage manufacturers, therefore, must pay close attention to the latest drugs coming through the pipeline and anticipate what products will be needed to meet consumers needs.
Frequently Asked Questions about The GLP-1 Plateau What is the medically accepted definition of a weight loss plateau
If youre curious about how these peptides could work in a personalized protocol, consult with a provider who understands both functional medicine and performance physiology